STEM CELL THERAPEUTIC

MEDIPOST, announces the clinical trial achievements at Bio USA

MEDIPOST, announces a domestic and international clinical experience at the ISCT annual meeting

Results from the US Clinical Trial of PNEUMOSTEM for Treating Lung Disease is Published in International Journal

MEDIPOST Registers US Patent for the Treatment of Lung Diseases

MEDIPOST Clears Product Approval Renewal of CARTISTEM by the Ministry of Food and Drug Safety(MFDS)

MEDIPOST, acquires a Japanese patent for the mesenchymal stem cell culture method

MEDIPOST, ends phase I and II clinical trials with PNEUMOSTEM, the effective treatment of BPD for preterm infants

MEDIPOST signs a joint research agreement with LG Chemical

MEDIPOST, signs a contract with SK Bioland for an ankle joint indication

MEDIPOST acquires US Patent for the ‘Mesenchymal Stem Cell Culture Method’

MEDIPOST acquires the patent in Mexico for ‘CARTISTEM’

MEDIPOST acquires the Japanese patent in hair loss prevention and hair growth promoting composition